Cargando…

Ultrasound in chronic liver disease

BACKGROUND: With the high prevalence of diffuse liver disease there is a strong clinical need for noninvasive detection and grading of fibrosis and steatosis as well as detection of complications. METHODS: B-mode ultrasound supplemented by portal system Doppler and contrast-enhanced ultrasound are t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerstenmaier, J. F., Gibson, R. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141343/
https://www.ncbi.nlm.nih.gov/pubmed/24859758
http://dx.doi.org/10.1007/s13244-014-0336-2
_version_ 1782331636869758976
author Gerstenmaier, J. F.
Gibson, R. N.
author_facet Gerstenmaier, J. F.
Gibson, R. N.
author_sort Gerstenmaier, J. F.
collection PubMed
description BACKGROUND: With the high prevalence of diffuse liver disease there is a strong clinical need for noninvasive detection and grading of fibrosis and steatosis as well as detection of complications. METHODS: B-mode ultrasound supplemented by portal system Doppler and contrast-enhanced ultrasound are the principal techniques in the assessment of liver parenchyma and portal venous hypertension and in hepatocellular carcinoma surveillance. RESULTS: Fibrosis can be detected and staged with reasonable accuracy using Transient Elastography and Acoustic Radiation Force Imaging. Newer elastography techniques are emerging that are undergoing validation and may further improve accuracy. Ultrasound grading of hepatic steatosis currently is predominantly qualitative. CONCLUSION: A summary of methods including B-mode, Doppler, contrast-enhanced ultrasound and various elastography techniques, and their current performance in assessing the liver, is provided. TEACHING POINTS: • Diffuse liver disease is becoming more prevalent and there is a strong clinical need for noninvasive detection. • Portal hypertension can be best diagnosed by demonstrating portosystemic collateral venous flow. • B-mode US is the principal US technique supplemented by portal system Doppler. • B-mode US is relied upon in HCC surveillance, and CEUS is useful in the evaluation of possible HCC. • Fibrosis can be detected and staged with reasonable accuracy using TE and ARFI. • US detection of steatosis is currently reasonably accurate but grading of severity is of limited accuracy.
format Online
Article
Text
id pubmed-4141343
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-41413432014-08-29 Ultrasound in chronic liver disease Gerstenmaier, J. F. Gibson, R. N. Insights Imaging Review BACKGROUND: With the high prevalence of diffuse liver disease there is a strong clinical need for noninvasive detection and grading of fibrosis and steatosis as well as detection of complications. METHODS: B-mode ultrasound supplemented by portal system Doppler and contrast-enhanced ultrasound are the principal techniques in the assessment of liver parenchyma and portal venous hypertension and in hepatocellular carcinoma surveillance. RESULTS: Fibrosis can be detected and staged with reasonable accuracy using Transient Elastography and Acoustic Radiation Force Imaging. Newer elastography techniques are emerging that are undergoing validation and may further improve accuracy. Ultrasound grading of hepatic steatosis currently is predominantly qualitative. CONCLUSION: A summary of methods including B-mode, Doppler, contrast-enhanced ultrasound and various elastography techniques, and their current performance in assessing the liver, is provided. TEACHING POINTS: • Diffuse liver disease is becoming more prevalent and there is a strong clinical need for noninvasive detection. • Portal hypertension can be best diagnosed by demonstrating portosystemic collateral venous flow. • B-mode US is the principal US technique supplemented by portal system Doppler. • B-mode US is relied upon in HCC surveillance, and CEUS is useful in the evaluation of possible HCC. • Fibrosis can be detected and staged with reasonable accuracy using TE and ARFI. • US detection of steatosis is currently reasonably accurate but grading of severity is of limited accuracy. Springer Berlin Heidelberg 2014-05-24 /pmc/articles/PMC4141343/ /pubmed/24859758 http://dx.doi.org/10.1007/s13244-014-0336-2 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Review
Gerstenmaier, J. F.
Gibson, R. N.
Ultrasound in chronic liver disease
title Ultrasound in chronic liver disease
title_full Ultrasound in chronic liver disease
title_fullStr Ultrasound in chronic liver disease
title_full_unstemmed Ultrasound in chronic liver disease
title_short Ultrasound in chronic liver disease
title_sort ultrasound in chronic liver disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141343/
https://www.ncbi.nlm.nih.gov/pubmed/24859758
http://dx.doi.org/10.1007/s13244-014-0336-2
work_keys_str_mv AT gerstenmaierjf ultrasoundinchronicliverdisease
AT gibsonrn ultrasoundinchronicliverdisease